Apogee Therapeutics, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.10 | — | — | Miss |
| Q12026 FY2026 | $-1.12 | $-1.06 | +5.4% | Beat |
| 2026-03-02 | $-1.05 | — | — | Miss |
Back to APGE overview · APGE holders · APGE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.